Geant4-DNA simulation of human cancer cells irradiation with helium ion beams.


Journal

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)
ISSN: 1724-191X
Titre abrégé: Phys Med
Pays: Italy
ID NLM: 9302888

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 20 02 2023
revised: 03 05 2023
accepted: 30 05 2023
medline: 16 8 2023
pubmed: 26 6 2023
entrez: 25 6 2023
Statut: ppublish

Résumé

This study aimed to develop a computational environment for the accurate simulation of human cancer cell irradiation using Geant4-DNA. New cell geometrical models were developed and irradiated by alpha particle beams to induce DNA damage. The proposed approach may help further investigation of the benefits of external alpha irradiation therapy. The Geant4-DNA Monte Carlo (MC) toolkit allows the simulation of cancer cell geometries that can be combined with accurate modelling of physical, physicochemical and chemical stages of liquid water irradiation, including radiolytic processes. Geant4-DNA is used to calculate direct and non-direct DNA damage yields, such as single and double strand breaks, produced by the deposition of energy or by the interaction of DNA with free radicals. In this study, the "molecularDNA" example application of Geant4-DNA was used to quantify early DNA damage in human cancer cells upon irradiation with alpha particle beams, as a function of linear energy transfer (LET). The MC simulation results are compared to experimental data, as well as previously published simulation data. The simulation results agree well with the experimental data on DSB yields in the lower LET range, while the experimental data on DSB yields are lower than the results obtained with the "molecularDNA" example in the higher LET range. This study explored and demonstrated the possibilities of the Geant4-DNA toolkit together with the "molecularDNA" example to simulate the helium beam irradiation of cancer cell lines, to quantify the early DNA damage, or even the following DNA damage response.

Identifiants

pubmed: 37356419
pii: S1120-1797(23)00090-X
doi: 10.1016/j.ejmp.2023.102613
pii:
doi:

Substances chimiques

Helium 206GF3GB41
DNA 9007-49-2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102613

Informations de copyright

Copyright © 2023 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Konstantinos Chatzipapas (K)

University of Bordeaux, CNRS, LP2i, UMR5797, F-33170 Gradignan, France.

Milos Dordevic (M)

Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 11351 Vinca, Belgrade, Serbia. Electronic address: milos.djordjevic@cern.ch.

Sara Zivkovic (S)

Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 11351 Vinca, Belgrade, Serbia.

Ngoc Hoang Tran (NH)

University of Bordeaux, CNRS, LP2i, UMR5797, F-33170 Gradignan, France.

Nathanael Lampe (N)

Independent researcher, Melbourne, Australia.

Dousatsu Sakata (D)

Division of Health Sciences, Osaka University, Osaka 565-0871, Japan.

Ivan Petrovic (I)

Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 11351 Vinca, Belgrade, Serbia.

Aleksandra Ristic-Fira (A)

Vinca Institute of Nuclear Sciences, National Institute of the Republic of Serbia, University of Belgrade, Mike Petrovica Alasa 12-14, 11351 Vinca, Belgrade, Serbia.

Wook-Geun Shin (WG)

Physics Division, Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, 02114 MA, USA.

Sara Zein (S)

University of Bordeaux, CNRS, LP2i, UMR5797, F-33170 Gradignan, France.

Jeremy M C Brown (JMC)

Optical Sciences Centre, Department of Physics and Astronomy, Swinburne University of Technology, Hawthorn 3122, Australia.

Ioanna Kyriakou (I)

Medical Physics Laboratory, Department of Medicine, University of Ioannina, 45110 Ioannina, Greece.

Dimitris Emfietzoglou (D)

Medical Physics Laboratory, Department of Medicine, University of Ioannina, 45110 Ioannina, Greece.

Susanna Guatelli (S)

Centre for Medical Radiation Physics, University of Wollongong, Wollongong, NSW 2522, Australia.

Sebastien Incerti (S)

University of Bordeaux, CNRS, LP2i, UMR5797, F-33170 Gradignan, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH